Research Groups

Mechanisms of Carcinogenesis - Molecular Mechanisms and Biomarkers Group

Previous Publications - All publications 2015-2011

1. Krais A.M., Muhlbauer K.R., Kucab J.E., Chinbuah H., Cornelius M.G., Wei Q.X., Hollstein M., Phillips D.H., Arlt V.M., Schmeiser H.H. (2015) Comparison of the metabolic activation of environmental carcinogens in mouse embryonic stem cells and mouse embryonic fibroblasts Toxicol In Vitro; 29(1):34-43. PMID: 25230394

2. Ose J., Fortner R.T., Schock H., Peeters P.H., Onland-Moret N.C., Bueno-de-Mesquita H.B., Weiderpass E., Gram I.T., Overvad K., Tjonneland A., Dossus L., Fournier A., Baglietto L., Trichopoulou A., Benetou V., Trichopoulos D., Boeing H., Masala G., Krogh V., Matiello A., Tumino R., Popovic M., Obon-Santacana M., Larranaga N., Ardanaz E., Sanchez M., Menendez V., Chirlaque M., Travis R.C., Khaw K., Brandstedt J., Idahl A., Lundin E., Rinaldi S., Kuhn E., Romieu I., Gunter M.J., Merritt M.A., Riboli E., Kaaks R. (2015) Insulin-like growth factor I and risk of epithelial invasive ovarian cancer by tumour characteristics: results from the EPIC cohort British journal of cancer; 112(1):162-166. PMID: 25349976

3. SEQC/MAQC-III Consortium (2014) A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium Nat Biotechnol.; 32(9):903-914. PMID: 25150838

4. Couraud S., Vaca-Paniagua F., Villar S., Oliver J., Schuster T., Blanche H., Girard N., Tredaniel J., Guilleminault L., Gervais R., Prim N., Vincent M., Margery J., Larive S., Foucher P., Duvert B., Vallee M., Le Calvez-Kelm F., McKay J., Missy P., Morin F., Zalcman G., Olivier M., Souquet P.J. (2014) Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-Smokers: A Proof-of-Concept Study from BioCAST/IFCT-1002 Clinical cancer research; 20(17):4613-4624. PMID: 25013125

5. Ma X., Rousseau V., Sun H., Lantuejoul S., Filipits M., Pirker R., Popper H., Mendiboure J., Vataire A.L., Le Chevalier T., Soria J.C., Brambilla E., Dunant A., Hainaut P. (2014) Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer Mol.Oncol; 8(3):555-564. PMID: 24495481

6. Sagne C., Marcel V., Bota M., Martel-Planche G., Nobrega A., Palmero E.I., Perriaud L., Boniol M., Vagner S., Cox D.G., Chan C.S., Mergny J.L., Olivier M., Ashton-Prolla P., Hall J., Hainaut P., Achatz M.I. (2014) Age at cancer onset in germline TP53 mutation carriers: association with polymorphisms in predicted G-quadruplex structures Carcinogenesis; 35(4):807-815. PMID: 24336192

7. Cortot A.B., Younes M., Martel-Planche G., Guibert B., Isaac S., Souquet P.J., Commo F., Girard P., Fouret P., Brambilla E., Hainaut P., Soria J.C. (2014) Mutation of TP53 and Alteration of p14(arf) Expression in EGFR- and KRAS-mutated lung adenocarcinomas. Clin Lung Cancer; 15(2):124-130. PMID: 24169260

8. Dai Y., Cros M.P., Pontoizeau C., Elena-Hermann B., Bonn G.K., Hainaut P. (2014) Downregulation of transcription factor E4F1 in hepatocarcinoma cells: HBV-dependent effects on autophagy, proliferation and metabolism Carcinogenesis; 35(3):635-650. PMID: 24163401

9. Giacomazzi J., Graudenz M.S., Osorio C.A., Koehler-Santos P., Palmero E.I., Zagonel-Oliveira M., Michelli R.A., Neto C.S., Fernandes G.C., Achatz M.I., Martel-Planche G., Soares F.A., Caleffi M., Goldim J.R., Hainaut P., Camey S.A., Ashton-Prolla P. (2014) Prevalence of the TP53 p.R337H Mutation in Breast Cancer Patients in Brazil PLoS ONE; 9(6):e99893. PMID: 24936644

10. Karanovic S., Tomic K., Dittrich D., Borovecki F., Zavadil J., Vukovic-Lela I., Karlovic K., Knezevic M., Jelakovic B. (2014) Endemic (Balkan) nephropathy is aristolochic acid nephropathy Prilozi.; 35(1):43-46. PMID: 24798595

11. Olivier M., Weninger A., Ardin M., Huskova H., Castells X., Vallee M.P., McKay J., Nedelko T., Muehlbauer K.R., Marusawa H., Alexander J., Hazelwood L., Byrnes G., Hollstein M., Zavadil J. (2014) Modelling mutational landscapes of human cancers in vitro Sci Rep.; 4482. PMID: 24670820

12. Scelo G., Riazalhosseini Y., Greger L., Letourneau L., Gonzalez-Porta M., Wozniak M.B., Bourgey M., Harnden P., Egevad L., Jackson S.M., Karimzadeh M., Arseneault M., Lepage P., How-Kit A., Daunay A., Renault V., Blanche H., Tubacher E., Sehmoun J., Viksna J., Celms E., Opmanis M., Zarins A., Vasudev N.S., Seywright M., Abedi-Ardekani B., Carreira C., Selby P.J., Cartledge J.J., Byrnes G., Zavadil J., Su J., Holcatova I., Brisuda A., Zaridze D., Moukeria A., Foretova L., Navratilova M., Mates D., Jinga V., Artemov A., Nedoluzhko A., Mazur A., Rastorguev S., Boulygina E., Heath S., Gut M., Bihoreau M.T., Lechner D., Foglio M., Gut I.G., Skryabin K., Prokhortchouk E., Cambon-Thomsen A., Rung J., Bourque G., Brennan P., Tost J., Banks R.E., Brazma A., Lathrop G.M. (2014) Variation in genomic landscape of clear cell renal cell carcinoma across Europe Nat Commun.; 5135. PMID: 25351205

13. Ortiz-Cuaran S., Cox D., Villar S., Friesen M.D., Durand G., Chabrier A., Khuhaprema T., Sangrajrang S., Ognjanovic S., Groopman J.D., Hainaut P., Le Calvez-Kelm F. (2013) Association between TP53 R249S mutation and polymorphisms in TP53 intron 1 in hepatocellular carcinoma Genes Chromosomes.Cancer; 52(10):912-919. PMID: 23836507

14. Sighoko D., Kamate B., Traore C., Malle B., Coulibaly B., Karidiatou A., Diallo C., Bah E., McCormack V., Muwonge R., Bourgeois D., Gormally E., Curado M.P., Bayo S., Hainaut P. (2013) Breast cancer in pre-menopausal women in West Africa: analysis of temporal trends and evaluation of risk factors associated with reproductive life Breast; 22(5):828-835. PMID: 23489760

15. Hollstein M., Moriya M., Grollman A.P., Olivier M. (2013) Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid Mutat.Res.; 753(1):41-49. PMID: 23422071

16. Shepherd F.A., Domerg C., Hainaut P., Janne P.A., Pignon J.P., Graziano S., Douillard J.Y., Brambilla E., Le Chevalier T., Seymour L., Bourredjem A., Le Teuff G., Pirker R., Filipits M., Rosell R., Kratzke R., Bandarchi B., Ma X., Capelletti M., Soria J.C., Tsao M.S. (2013) Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy Journal of clinical oncology; 31(17):2173-2181. PMID: 23630215

17. Lu X., Wontakal S.N., Kavi H., Kim B.J., Guzzardo P.M., Emelyanov A.V., Xu N., Hannon G.J., Zavadil J., Fyodorov D.V., Skoultchi A.I. (2013) Drosophila H1 regulates the genetic activity of heterochromatin by recruitment of Su(var)3-9 Science; 340(6128):78-81. PMID: 23559249

18. Ortiz-Cuaran S., Villar S., Gouas D., Ferro G., Plymoth A., Khuhaprema T., Kalalak A., Sangrajrang S., Friesen M.D., Groopman J.D., Hainaut P. (2013) Association between HBX status, aflatoxin-induced R249S TP53 mutation and risk of hepatocellular carcinoma in a case-control study from Thailand Cancer letters; 331(1):46-51. PMID: 23200676

19. Dichtel-Danjoy M.L., Ma D., Dourlen P., Chatelain G., Napoletano F., Robin M., Corbet M., Levet C., Hafsi H., Hainaut P., Ryoo H.D., Bourdon J.C., Mollereau B. (2013) Drosophila p53 isoforms differentially regulate apoptosis and apoptosis-induced proliferation Cell Death.Differ.; 20(1):108-116. PMID: 22898807

20. Fye H.K., Wright-Drakesmith C., Kramer H.B., Camey S., Nogueira da Costa A., Jeng A., Bah A., Kirk G.D., Sharif M.I., Ladep N.G., Okeke E., Hainaut P., Taylor-Robinson S.D., Kessler B.M., Mendy M.E. (2013) Protein profiling in hepatocellular carcinoma by label-free quantitative proteomics in two west African populations PLoS.One.; 8(7):e68381. PMID: 23935864

21. Hafsi H., Santos-Silva D., Courtois-Cox S., Hainaut P. (2013) Effects of Delta40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53 BMC.Cancer; 134. PMID: 23514281

22. Sagne C., Marcel V., Amadou A., Hainaut P., Olivier M., Hall J. (2013) A meta-analysis of cancer risk associated with the TP53 intron 3 duplication polymorphism (rs17878362): geographic and tumor-specific effects Cell Death.Dis; e492. PMID: 23412385

23. Gouas D.A., Villar S., Ortiz-Cuaran S., Legros P., Ferro G., Kirk G.D., Lesi O.A., Mendy M., Bah E., Friesen M.D., Groopman J., Chemin I., Hainaut P. (2012) TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia Carcinogenesis; 33(6):1219-1224. PMID: 22759751

24. Gembarska A., Luciani F., Fedele C., Russell E.A., Dewaele M., Villar S., Zwolinska A., Haupt S., de Lange J., Yip D., Goydos J., Haigh J.J., Haupt Y., Larue L., Jochemsen A., Shi H., Moriceau G., Lo R.S., Ghanem G., Shackleton M., Bernal F., Marine J.C. (2012) MDM4 is a key therapeutic target in cutaneous melanoma Nature Medicine; 18(8):1239-1247. PMID: 22820643

25. Scoccianti C., Vesin A., Martel G., Olivier M., Brambilla E., Timsit J.F., Tavecchio L., Brambilla C., Field J.K., Hainaut P. (2012) Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: the EUELC cohort European respiratory journal; 40(1):177-184. PMID: 22267755

26. de Fraipont F., Levallet G., Creveuil C., Bergot E., Beau-Faller M., Mounawar M., Richard N., Antoine M., Rouquette I., Favrot M.C., Debieuvre D., Braun D., Westeel V., Quoix E., Brambilla E., Hainaut P., Moro-Sibilot D., Morin F., Milleron B., Zalcman G. (2012) An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial Clinical cancer research; 18(10):2976-2986. PMID: 22434665

27. Shang S., Plymoth A., Ge S., Feng Z., Rosen H.R., Sangrajrang S., Hainaut P., Marrero J.A., Beretta L. (2012) Identification of osteopontin as a novel marker for early hepatocellular carcinoma Hepatology; 55(2):483-490. PMID: 21953299

28. Blandino G., Deppert W., Hainaut P., Levine A., Lozano G., Olivier M., Rotter V., Wiman K., Oren M. (2012) Mutant p53 protein, master regulator of human malignancies: a report on the fifth Mutant p53 Workshop Cell death and differentiation; 19(1):180-183. PMID: 22095277

29. Hainaut P., Plymoth A. (2012) Cancer as a metabolic disease Current opinion in oncology; 24(1):56-57. PMID: 22143370

30. Abedi-Ardekani B., Dar N.A., Mir M.M., Zargar S.A., Lone M.M., Martel-Planche G., Villar S., Mounawar M., Saidi F., Malekzadeh R., Hainaut P. (2012) Epidermal growth factor receptor (EGFR) mutations and expression in squamous cell carcinoma of the esophagus in central Asia BMC.Cancer; 602. PMID: 23244191

31. Fernandez-Cuesta L., Oakman C., Falagan-Lotsch P., Smoth K.S., Quinaux E., Buyse M., Dolci M.S., Azambuja E.D., Hainaut P., Dell'orto P., Larsimont D., Francis P.A., Crown J., Piccart-Gebhart M., Viale G., Leo A.D., Olivier M. (2012) Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial Breast cancer research; 14(3):R70. PMID: 22551440

32. Ognjanovic S., Martel G., Manivel C., Olivier M., Langer E., Hainaut P. (2012) Low Prevalence of TP53 Mutations and MDM2 Amplifications in Pediatric Rhabdomyosarcoma Sarcoma; 492086. PMID: 22550420

33. Villar S., Ortiz-Cuaran S., Abedi-Ardekani B., Gouas D., Nogueira da Costa A., Plymoth A., Khuhaprema T., Kalalak A., Sangrajrang S., Friesen M.D., Groopman J.D., Hainaut P. (2012) Aflatoxin-Induced TP53 R249S Mutation in HepatoCellular Carcinoma in Thailand: Association with Tumors Developing in the Absence of Liver Cirrhosis PLoS ONE; 7(6):e37707. PMID: 22675488

34. Balassiano K., Lima S., Jenab M., Overvad K., Tjonneland A., Boutron-Ruault M.C., Clavel-Chapelon F., Canzian F., Kaaks R., Boeing H., Meidtner K., Trichopoulou A., Laglou P., Vineis P., Panico S., Palli D., Grioni S., Tumino R., Lund E., Bueno-de-Mesquita H.B., Numans M.E., Peeters P.H., Ramon Quiros J., Sanchez M.A., Navarro C., Ardanaz E., Dorronsoro M., Hallmans G., Stenling R., Ehrnstrom R., Regner S., Allen N.E., Travis R.C., Khaw K.T., Offerhaus G.J., Sala N., Riboli E., Hainaut P., Scoazec J.Y., Sylla B.S., Gonzalez C.A., Herceg Z. (2011) Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) Cancer letters; 311(1):85-95. PMID: 21831520

35. da Silva E.M., Achatz M.I., Martel-Planche G., Montagnini A.L., Olivier M., Prolla P.A., Hainaut P., Soares F.A. (2011) TP53 mutation p.R337H in gastric cancer tissues of a 12-year-old male child - evidence for chimerism involving a common mutant founder haplotype: case report BMC cancer; 11(1):449. PMID: 22004116

36. Hafsi H., Hainaut P. (2011) Redox Control and Interplay Between p53 Isoforms: Roles in the Regulation of Basal p53 Levels, Cell Fate, and Senescence Antioxidants & redox signaling; 15(6):1655-1667. PMID: 21194382

37. Krais A.M., Hautefeuille A.H., Cros M.P., Krutovskikh V., Tournier J.M., Birembaut P., Thepot A., Paliwal A., Herceg Z., Boffetta P., Brennan P., Hainaut P.L. (2011) CHRNA5 as negative regulator of nicotine signaling in normal and cancer bronchial cells: effects on motility, migration and p63 expression Carcinogenesis; 32(9):1388-1395. PMID: 21586512

38. Moore H.M., Kelly A.B., Jewell S.D., McShane L.M., Clark D.P., Greenspan R., Hayes D.F., Hainaut P., Kim P., Mansfield E., Potapova O., Riegman P., Rubinstein Y., Seijo E., Somiari S., Watson P., Weier H.U., Zhu C., Vaught J. (2011) Biospecimen Reporting for Improved Study Quality (BRISQ) J Proteome Res; 10(8):3429-3438. PMID: 21574648

39. Beau-Faller M., Degeorges A., Rolland E., Mounawar M., Antoine M., Poulot V., Mauguen A., Barbu V., Coulet F., Pretet J.L., Bieche I., Blons H., Boyer J.C., Buisine M.P., de Fraipont F., Lizard S., Olschwang S., Saulnier P., Prunier-Mirebeau D., Richard N., Danel C., Brambilla E., Chouaid C., Zalcman G., Hainaut P., Michiels S., Cadranel J. (2011) Cross-Validation Study for Epidermal Growth Factor Receptor and KRAS Mutation Detection in 74 Blinded Non-small Cell Lung Carcinoma Samples: A Total of 5550 Exons Sequenced by 15 Molecular French Laboratories (Evaluation of the EGFR Mutation Status for the Administration of EGFR-TKIs in Non-Small Cell Lung Carcinoma [ERMETIC] Project-Part 1) J Thorac Oncol; 6(6):1006-1015. PMID: 21532509

40. Nogueira da Costa A., Mijal R.S., Keen J.N., Findlay J.B., Wild C.P. (2011) Proteomic analysis of the effects of the immunomodulatory mycotoxin deoxynivalenol Proteomics; 11(10):1903-1914. PMID: 21462343

41. Brennan P., Hainaut P., Boffetta P. (2011) Genetics of lung-cancer susceptibility Lancet oncology; 12(4):399-408. PMID: 20951091

42. Fernandez-Cuesta L., Anaganti S., Hainaut P., Olivier M. (2011) p53 status influences response to tamoxifen but not to fulvestrant in breast cancer cell lines International journal of cancer; 128(8):1813-1821. PMID: 20549698

43. Lambert M.P., Paliwal A., Vaissiere T., Chemin I., Zoulim F., Tommasino M., Hainaut P., Sylla B., Scoazec J.Y., Tost J., Herceg Z. (2011) Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake J Hepatol; 54(4):705-715. PMID: 21146512

44. Moore H.M., Kelly A.B., Jewell S.D., McShane L.M., Clark D.P., Greenspan R., Hayes D.F., Hainaut P., Kim P., Mansfield E.A., Potapova O., Riegman P., Rubinstein Y., Seijo E., Somiari S., Watson P., Weier H.U., Zhu C., Vaught J. (2011) Biospecimen reporting for improved study quality (BRISQ) Cancer Cytopathol; 119(2):92-102. PMID: 21433001

45. Moore H.M., Kelly A., Jewell S.D., McShane L.M., Clark D.P., Greenspan R., Hainaut P., Hayes D.F., Kim P., Mansfield E., Potapova O., Riegman P., Rubinstein Y., Seijo E., Somiari S., Watson P., Weier H.U., Zhu C., Vaught J. (2011) Biospecimen Reporting for Improved Study Quality Biopreserv Biobank; 9(1):57-70. PMID: 21826252

46. Hafsi H., Hainaut P. (2011) Pharmacological rescue of p53 in cancer cells: The soloist meets the PRIMA donna Cell Cycle; 10(6):875-876. PMID: 21358263

47. Marcel V., Tran P.L., Sagne C., Martel-Planche G., Vaslin L., Teulade-Fichou M.P., Hall J., Mergny J.L., Hainaut P., Van Dyck E. (2011) G-quadruplex structures in TP53 intron 3: role in alternative splicing and in production of p53 mRNA isoforms Carcinogenesis; 32(3):271-278. PMID: 21112961

48. Marcel V., Olivier M., Mollereau B., Hainaut P., Bourdon J.C. (2011) First International p53 Isoforms Meeting: 'p53 isoforms through evolution: from identification to biological function' Cell death and differentiation; 18(3):563-564. PMID: 21151028

49. Umoh N.J., Lesi O.A., Mendy M., Bah E., Akano A., Whittle H., Hainaut P., Kirk G.D. (2011) Aetiological differences in demographical, clinical and pathological characteristics of hepatocellular carcinoma in The Gambia Liver International; 31(2):215-221. PMID: 21143369

50. Anaganti S., Fernandez-Cuesta L., Langerod A., Hainaut P., Olivier M. (2011) p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-lines Cancer letters; 300(2):215-224. PMID: 21071137

51. Fernandez-Cuesta L., Anaganti S., Hainaut P., Olivier M. (2011) Estrogen levels act as a rheostat on p53 levels and modulate p53-dependent responses in breast cancer cell lines Breast cancer research and treatment; 125(1):35-42. PMID: 20221692

52. Franceschi S., Lise M., Trepo C., Berthillon P., Chuang S.C., Nieters A., Travis R.C., Vermeulen R., Overvad K., Tjonneland A., Olsen A., Bergmann M.M., Boeing H., Kaaks R., Becker N., Trichopoulou A., Lagiou P., Bamia C., Palli D., Sieri S., Panico S., Tumino R., Sacerdote C., Bueno-de-Mesquita B., Peeters P.H., Rodriguez L., Barroso L.L., Dorronsoro M., Sanchez M.J., Navarro C., Barricarte A., Regner S., Borgquist S., Melin B., Hallmans G., Khaw K.T., Wareham N., Rinaldi S., Hainaut P., Riboli E., Vineis P. (2011) Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cancer epidemiology, biomarkers & prevention; 20(1):208-214. PMID: 21098651

53. Goldstein I., Marcel V., Olivier M., Oren M., Rotter V., Hainaut P. (2011) Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies Cancer Gene Therapy; 18(1):2-11. PMID: 20966976

54. Hainaut P., Plymoth A. (2011) Biomarkers in cancer research and treatment: promises and challenges Current opinion in oncology; 23(1):61. PMID: 21321519

55. Olivier M., Taniere P. (2011) Somatic mutations in cancer prognosis and prediction: lessons from TP53 and EGFR genes Current opinion in oncology; 23(1):88-92. PMID: 21045690

56. Pfeifer G.P., Hainaut P. (2011) Next-generation sequencing: emerging lessons on the origins of human cancer Current opinion in oncology; 23(1):62-68. PMID: 21119514

57. Plymoth A., Hainaut P. (2011) Proteomics beyond proteomics: toward clinical applications Current opinion in oncology; 23(1):77-82. PMID: 21107258

58. Abedi-Ardekani B., Kamangar F., Sotoudeh M., Villar S., Islami F., Aghcheli K., Nasrollahzadeh D., Taghavi N., Dawsey S.M., Abnet C.C., Hewitt S.M., Fahimi S., Saidi F., Brennan P., Boffetta P., Malekzadeh R., Hainaut P. (2011) Extremely high tp53 mutation load in esophageal squamous cell carcinoma in golestan province, iran PLoS ONE; 6(12):e29488. PMID: 22216294

59. Abedi-Ardekani B., Gouas D., Villar S., Sotoudeh M., Hainaut P. (2011) TP53 Mutations and HBX Status Analysis in Hepatocellular Carcinomas from Iran: Evidence for Lack of Association between HBV Genotype D and TP53 R249S Mutations Hepat Res Treat; 475965. PMID: 21869931

60. Galy O., Chemin I., Le Roux E., Villar S., Le Calvez-Kelm F., Lereau M., Gouas D., Vieco B., Suarez I., Navas M.C., Chevallier M., Norder H., Srivatanakul P., Karalak A., Sangrajrang S., Trepo C., Hainaut P. (2011) Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from Thailand Hepat Res Treat; doi:10.1155/2011/697. PMID: 21760996

61. Hainaut P., Vozar B., Rinaldi S., Riboli E., Caboux E. (2011) The European Prospective Investigation into Cancer and Nutrition biobank Methods in Molecular Biology; 179-191. PMID: 20949388

62. Hewitt R., Hainaut P. (2011) Biobanking in a fast moving world: an international perspective J Natl Cancer Inst Monogr; 2011(42):50-51. PMID: 21672898

63. Navas M.C., Suarez I., Carreno A., Uribe D., Rios W.A., Cortes-Mancera F., Martel G., Vieco B., Lozano D., Jimenez C., Gouas D., Osorio G., Hoyos S., Restrepo J.C., Correa G., Jaramillo S., Lopez R., Bravo L.E., Arbelaez M.P., Scoazec J.Y., Abedi-Ardekani B., Santella R.M., Chemin I., Hainaut P. (2011) Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia Hepat Res Treat; 582945. PMID: 22114738

64. Sighoko D., Curado M.P., Bourgeois D., Mendy M., Hainaut P., Bah E. (2011) Increase in female liver cancer in the gambia, west Africa: evidence from 19 years of population-based cancer registration (1988-2006) PLoS ONE; 6(4):e18415. PMID: 21490972

65. Thepot A., Desanlis A., Venet E., Thivillier L., Justin V., Morel A.P., Defraipont F., Till M., Krutovskikh V., Tommasino M., Damour O., Hainaut P. (2011) Assessment of transformed properties in vitro and of tumorigenicity in vivo in primary keratinocytes cultured for epidermal sheet transplantation J Skin Cancer; 936546. PMID: 21188234